Peers

Kilitch Drugs (India) Ltd. demonstrates strong growth potential with a respectable profitability profile, making it competitive within the pharmaceuticals sector, particularly against peers with higher valuations. However, some companies stand out as better value picks and stronger performers overall.

• • Kilitch Drugs shows solid revenue growth and good return metrics compared to peers.
• • Sun Pharmaceuticals and Divi's Laboratories are among the most overvalued, while Kilitch presents a more attractive valuation based on its growth.
• • Cipla and Dr. Reddy's Laboratories rank highly in terms of profitability and efficiency.

• • Dr. Reddy's Laboratories Ltd.: High ROE (21.76%), strong EPS growth and low PE (15.50) make it a standout.
• • Cipla Ltd.: Impressive profitability metrics with a reasonable PE (23.73) and solid growth.
• • Kilitch Drugs (India) Ltd.: Strong revenue growth (YoY: 28.47%) and decent profitability metrics (ROE: 8.43%).